University Hospital North Norway Tromsø
Tromsø, 9038, Norway
NCT Number: NCT01965548
In blunt trauma, the spleen is most frequent injured organ in the abdomen and the most frequent source of bleeding in the abdomen.
Historically, splenectomy was the treatment of choice for splenic bleeding. For exsanguinating patients, open splenectomy is still the proper choice of treatment if the spleen is a significant source of bleeding. However, for hemodynamic stable patients with splenic injury, non-operative management (NOM) is an alternative, assuming they have no other indication for surgery (peritonitis).
Non-operative management includes observation and/or splenic artery embolisation (SAE), but the indications for observation and SAE varies between trauma centers. The greatest advantage of NOM is the preservation of splenic function.
In the investigators hospital splenic artery embolisation was introduced in 2007. The investigators want to describe the treatment of splenic injuries in their hospital, to see if the number of splenectomies has been recduced after 2007, and to see if SAE has also been used in transferred trauma patients.
Looking for future studies?
Notify MeAll sexes
Observational
Tromsø, 9038, Norway
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
There are four possible treatments of splenic injury in this study:
Time frame: 0-7 days
There are three different treatments of splenic trauma treatment, resulting in four different treatments:
Time frame: 30 days
Time frame: 1 - 90 days
Time frame: 0 - 90 days
Time frame: 0 - 7 days
Emergency procedures includes:
University Hospital of North Norway
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03778307
Endothelial Dysfunction, Mental Disorders
Los Angeles, California, United States
View Trial DetailsNCT03973229
Mental Disorders, PTSD
Atlanta, Georgia, United States
View Trial DetailsNCT05510362
Infections, Opportunistic Infections
Monastir, Monastir Governorate, Tunisia
View Trial DetailsNCT07256405
Bone, Fracture
Marseille, Bouches-du-Rhône, France
View Trial Details